SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-142114
Filing Date
2023-05-11
Accepted
2023-05-11 16:45:56
Documents
15
Period of Report
2023-05-11
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d494076d8k.htm   iXBRL 8-K 29057
2 EX-1.1 d494076dex11.htm EX-1.1 173157
3 EX-5.1 d494076dex51.htm EX-5.1 9256
7 GRAPHIC g494076g0510222241181.jpg GRAPHIC 2409
  Complete submission text file 0001193125-23-142114.txt   388085

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA advm-20230511.xsd EX-101.SCH 2851
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE advm-20230511_lab.xml EX-101.LAB 17236
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE advm-20230511_pre.xml EX-101.PRE 10813
9 EXTRACTED XBRL INSTANCE DOCUMENT d494076d8k_htm.xml XML 3207
Mailing Address 100 CARDINAL WAY REDWOOD CITY CA 94063
Business Address 100 CARDINAL WAY REDWOOD CITY CA 94063 (650) 649-1004
Adverum Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36579 | Film No.: 23911812
SIC: 2836 Biological Products, (No Diagnostic Substances)